The alteration of cholinergic systems is involved in many neurodegenerative disorders, including Alzheimer’s disease [8], hence a huge effort has been devoted over the decades to discovering and developing AChE inhibitors that can contrast cognitive impairment. Here, ACHE is linked to Alzheimer disease.